Ibalizumab is a humanized monoclonal antibody that binds human CD4—a key receptor for HIV—and blocks HIV-1 infection. However, HIV-1 strains with mutations resulting in loss of an N-linked glycan from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback